title: Allele-specific expression of angiotensinogen in human subcutaneous adipose tissue.
abstract: The angiotensinogen gene is genetically linked with hypertension, but the mechanistic basis for association of sequence variants in the promoter and coding region of the gene remains unclear. An E-box at position -20 has been hypothesized to control the level of angiotensinogen expression, but its mechanistic importance for angiotensinogen expression in human tissues is uncertain. We developed an allele-specific polymerase chain reaction-based assay to distinguish between angiotensinogen mRNA derived from variants at the -20 position (rs5050) in the angiotensinogen promoter in adipose tissues obtained during surgery. The assay takes advantage of linkage disequilibrium between the rs5050 (located in the promoter) and rs4762 (located in the coding region) single nucleotide polymorphisms. This strategy allowed us to assess the level of allele-specific expression in A-20C heterozygous subjects comparing the relative proportion of each allele with the total, thus eliminating the problem of variability in the level of total angiotensinogen mRNA among subjects. We show that angiotensinogen mRNA derived from the -20C allele is expressed significantly higher than that derived from the -20A allele in subcutaneous adipose tissue, and increased expression correlates with enriched chromatin binding of upstream stimulatory factor-2 to the -20C E-box compared with -20A. This may be depot selective because we were unable to detect these differences in omental adipose. This provides the first data directly comparing expression of angiotensinogen mRNA and differential transcription factor binding derived from 2 variant alleles in human tissue where the ratio of expression of one allele to another can be accurately determined.
authors: Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
authors: Sungmi
authors: S
authors: Park
authors: Ko-Ting
authors: KT
authors: Lu
authors: Xuebo
authors: X
authors: Liu
authors: Tapan K
authors: TK
authors: Chatterjee
authors: Steven M
authors: SM
authors: Rudich
authors: Neal L
authors: NL
authors: Weintraub
authors: Anne E
authors: AE
authors: Kwitek
authors: Curt D
authors: CD
authors: Sigmund
mesh_terms: D000328:Adult; D000483:Alleles; D000808:Angiotensinogen / Q000096:biosynthesis / Q000235:genetics*; D005260:Female; D005786:Gene Expression Regulation; D020022:Genetic Predisposition to Disease; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D009765:Obesity / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000235:genetics*; D050151:Subcutaneous Fat / Q000378:metabolism
chemical_list: D012333:RNA, Messenger; D000808:Angiotensinogen
keywords: adipose tissue; angiotensinogen; genetics; hypertension; transcription factors; upstream stimulatory factors
references: Lancet. 1999 Feb 20;353(9153):611-6
references: 10030325
references: FASEB J. 2001 Dec;15(14):2727-9
references: 11606482
references: Am J Physiol Regul Integr Comp Physiol. 2012 Jan 15;302(2):R244-51
references: 22071160
references: Hypertension. 2008 Mar;51(3):778-83
references: 18227406
references: Kidney Int. 2002 Sep;62(3):980-5
references: 12164881
references: Am J Physiol Endocrinol Metab. 2007 May;292(5):E1280-7
references: 17213477
references: J Biol Chem. 1999 Jan 22;274(4):2009-13
references: 9890958
references: Circulation. 2002 Sep 17;106(12):1483-7
references: 12234952
references: Hypertension. 2001 Dec 1;38(6):1250-4
references: 11751698
references: Endocrinology. 2001 Dec;142(12):5220-5
references: 11713218
references: Am J Hum Genet. 2002 Jan;70(1):108-23
references: 11731937
references: Metabolism. 2010 Sep;59(9):1241-51
references: 20045538
references: Am J Hypertens. 2007 Sep;20(9):974-80
references: 17765139
references: J Biol Chem. 1995 May 12;270(19):11430-6
references: 7744780
references: N Engl J Med. 2006 Oct 12;355(15):1551-62
references: 16980380
references: Endocrinology. 2003 Jun;144(6):2179-83
references: 12746271
references: Mol Cell Endocrinol. 1999 Feb 25;148(1-2):79-86
references: 10221773
references: Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E891-5
references: 14749209
references: Endocrinology. 1997 Apr;138(4):1512-9
references: 9075710
references: Stroke. 2001 Feb;32(2):405-12
references: 11157174
references: Hypertension. 1999 Jan;33(1):108-15
references: 9931090
references: Hypertension. 2007 Mar;49(3):631-9
references: 17200439
references: J Biol Chem. 2011 Aug 5;286(31):27836-47
references: 21680747
references: J Hum Hypertens. 2010 Mar;24(3):213-9
references: 19536167
references: Hum Mol Genet. 2005 Sep 1;14(17):2595-605
references: 16076849
references: J Hypertens. 2000 May;18(5):553-7
references: 10826557
references: J Clin Invest. 1997 Apr 1;99(7):1786-97
references: 9120024
references: Hypertension. 2010 Nov;56(5):981-7
references: 20823378
references: Obes Rev. 2012 Feb;13(2):136-49
references: 22034852
references: Int J Mol Med. 2003 Aug;12(2):161-7
references: 12851711
references: Hypertension. 2006 Jul;48(1):14-20
references: 16754793
references: J Biol Chem. 2002 Sep 27;277(39):36889-96
references: 12145290
references: Hypertension. 2012 Jun;59(6):1212-9
references: 22547438
references: Circ Res. 2008 Oct 24;103(9):940-7
references: 18802024
references: Am J Hypertens. 2010 Apr;23(4):425-31
references: 20057360
references: Cell. 1992 Oct 2;71(1):169-80
references: 1394429
references: Hypertension. 2012 Dec;60(6):1524-30
references: 23108647
references: Physiol Genomics. 2002 Dec 3;11(3):253-62
references: 12388794